| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DELANEY MARK E | SVP & Chief Commercial Officer | 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS | Sean D. Mersten, Attorney in Fact for Mark E. Delaney | 20 Feb 2026 | 0001955265 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Common Stock | Award | $0 | +1,586 | +21% | $0.000000 | 9,116 | 18 Feb 2026 | Direct | F1 |
| transaction | DGX | Common Stock | Tax liability | $43,052 | -205 | -2.2% | $210.01 | 8,911 | 18 Feb 2026 | Direct | F2 |
| transaction | DGX | Common Stock | Tax liability | $47,608 | -230 | -2.6% | $206.99 | 8,681 | 18 Feb 2026 | Direct | F2 |
| transaction | DGX | Common Stock | Small acquisition under Rule 16a-6 | $2,753 | +15 | +0.17% | $183.51 | 8,696 | 28 Jan 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DGX | Non-Qualifed Stock Option (right to buy) | Award | $0 | +7,332 | $0.000000 | 7,332 | 18 Feb 2026 | Common Stock | 7,332 | $204.96 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | Represents an award of restricted stock units. |
| F2 | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. |
| F3 | Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
| F4 | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |